Association between interleukin 1β and interleukin 10 concentrations: a cross-sectional study in young adolescents in Taiwan

BMC Pediatrics

Kuo-Ching Chao¹  Chyi-Huey Bai³  Tsai Cheng-Shiuan⁴  Sean S-H Lin²  Eve Yiwen Chien²  Chun-Chao Chang¹  Jung-Su Chang² 

[1] Department of Internal Medicine, School of Medicine, College of medicine, Taipei Medical University, Taipei, 110, Taiwan R.O.C;School of Nutrition and Health Sciences, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan R.O.C;Department of Public Health, College of Medicine, Taipei Medical University, Taipei, Taiwan R.O.C;School of Public Health, Taipei Medical University, Taipei, Taiwan R.O.C

关键词: Taiwan;    Overweight and obese adolescents;    IL1β;    IL10;   

Others  :  1144616
DOI  :  10.1186/1471-2431-13-123

 received in 2013-01-24, accepted in 2013-08-07,  发布年份 2013

【 摘 要 】

Background

In adults, low circulating interleukin 10 (IL10) has been associated with obesity and type 2 diabetes. However, studies investigating IL10 in overweight and obese children have yielded conflicting results. The aim of this study was to investigate factors associated with serum IL10 concentration in young Chinese adolescents.

Methods

Young adolescents (n=325) ages 13.33±1.10 years were recruited into the cross-sectional study from 2010 to 2011. Parameters of obesity, individual components of MetS, iron status and serum IL10 were evaluated.

Results

Compared with their normal weight counterparts, overweight adolescents had lower serum IL10 but higher TNFα, nitric oxide (NO) and IL1β concentrations (all p<0.05). Obese adolescents had increased IL1β but decreased hepcidin concentration compared with normal weight (p<0.01 and p<0.05; respectively). A strong inverse relationship (p<0.0001) was found between IL10 and pro-inflammatory cytokines (TNFα and IL1β). Multivariate linear regression analysis showed serum IL1β was significantly correlated with IL10 (β=−0.156, p<0.0001). When overweight and obese adolescents were assessed separately from normal weight, only IL1β was inversely associated with serum IL10 (β=−0.231, p=0.0009). The association between IL10 and IL1β was weaker in adolescents with normal weight (β=−0.157, p=0.0002), after adjusting for gender, TNFα, IFNγ and NO.

Conclusions

Our study confirmed that low IL10 concentration is associated with overweight and obesity in young adolescents. We also demonstrated for the first time that pro-inflammatory cytokine IL1β is independently associated with IL10. A decline in IL10 concentration in overweight and obese adolescents may further contribute to the IL1β-mediated inflammatory environment associated with obesity.

【 授权许可】

   
2013 Chang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Rahim SS, Khan N, Boddupalli CS, Hasnain SE, Mukhopadhyay S: Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology 2005, 114:313-321.
• [2]Vasu C, Gorla SR, Prabhakar BS, Holterman MJ: Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int Immunol 2003, 15:641-654.
• [3]Couper KN, Blount DG, Riley EM: IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
• [4]Stoppa-Vaucher S, Dirlewanger MA, Meier CA, de Moerloose P, Reber G, Roux-Lombard P, Combescure C, Saudan S, Schwitzgebel VM: Inflammatory and prothrombotic states in obese children of European descent. Obesity (Silver Spring) 2012, 20:1662-1668.
• [5]Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K: Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J 2007, 71:1234-1238.
• [6]Bosutti A, Malaponte G, Zanetti M, Castellino P, Heer M, Guarnieri G, Biolo G: Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab 2008, 93:3226-3229.
• [7]Han X, Kitamoto S, Wang H, Boisvert WA: Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J 2010, 24:2869-2880.
• [8]Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM: Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003, 107:2109-2114.
• [9]Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC: Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001, 104:746-749.
• [10]Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, et al.: Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009, 58:2525-2535.
• [11]Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M: Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 2005, 28:2036-2037.
• [12]van Exel E, Gussekloo J, de Craen AJ, Frolich M, Bootsma-Van Der Wiel A, Westendorp RG: Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-plus study. Diabetes 2002, 51:1088-1092.
• [13]Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, Modlin RL: Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. The Journal of clinical investigation 1996, 97:2130-2138.
• [14]Forte GI, Pilato G, Vaccarino L, Sanacore M, Candore G, Romano GC, Testa R, Franceschi C, Capri M, Marra M, et al.: Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications. Curr Pharm Des 2010, 16:898-903.
• [15]Arslan N, Erdur B, Aydin A: Hormones and cytokines in childhood obesity. Indian Pediatr 2010, 47:829-839.
• [16]Calcaterra V, De Amici M, Klersy C, Torre C, Brizzi V, Scaglia F, Albanesi M, Albertini R, Allais B, Larizza D: Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed 2009, 80:117-123.
• [17]Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L: Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 2008, 9:254-259.
• [18]Tam CS, Garnett SP, Cowell CT, Heilbronn LK, Lee JW, Wong M, Baur LA: IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Horm Res Paediatr 2010, 73:128-134.
• [19]Tilg H, Ulmer H, Kaser A, Weiss G: Role of IL-10 for induction of anemia during inflammation. J Immunol 2002, 169:2204-2209.
• [20]Oldenburg B, van Berge Henegouwen GP, Rennick D, Van Asbeck BS, Koningsberger JC: Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000, 30:505-510.
• [21]Choy C, Huang Y, Liu Y, Yang C, Liao C, Li JS, Chiu W, Vhiou H: Waist circumference as a predictor of pediatric hypertension AAmong normal-weight Taiwanese children. J Exp Clin Med 2011, 3:34-39.
• [22]Pan WH, Lee MS, Chuang SY, Lin YC, Fu ML: Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan. Obes Rev 2008, 9(Suppl 1):22-31.
• [23]Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Exceutive summary of the third report of the national cholesterol education program (NCEP) (adult treatment panel III). JAMA 2001, 285:2486-2497.
• [24]Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diabetes Care 2004, 27:1182-1186.
• [25]Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S: The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatric diabetes 2007, 8:299-306.
• [26]Chu NF, Pan WH: Prevalence of obesity and its comorbidities among schoolchildren in Taiwan. Asia Pac J Clin Nutr 2007, 16(Suppl 2):601-607.
• [27]Wang JL, Shaw NS: Iron status of the Taiwanese elderly: the prevalence of iron deficiency and elevated iron stores. Asia Pac J Clin Nutr 2005, 14:278-284.
• [28]Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
• [29]Donath MY, Mandrup-Poulsen T: The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008, 4:240-241.
• [30]D'Adamo E, Caprio S: Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care 2011, 34(Suppl 2):S161-S165.
• [31]Corcoran MP, Meydani M, Lichtenstein AH, Schaefer EJ, Dillard A, Lamon-Fava S: Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol 2010, 206:217-224.
• [32]Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, et al.: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046-2049.
• [33]Milewicz A, Jedrzejuk D, Dunajska K, Lwow F: Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women. Maturitas 2010, 65:272-275.
• [34]Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007, 356:1517-1526.
• [35]He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, Iwata M, Bukhari A, Haruta T, Sasaoka T, Kobayashi M: Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol Endocrinol 2006, 20:114-124.
• [36]del Giudice EM, Santoro N, Amato A, Brienza C, Calabro P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L: Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009, 94:5102-5107.
• [37]Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004, 114:104-108.
• [38]Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8:240-246.
• [39]Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A: Genetic influence on cytokine production in meningococcal disease. Lancet 1997, 349:1912-1913.
• [40]Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G: Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian Italian subjects. Diabetes 2006, 55:1529-1533.
• [41]Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Chen CP, Tsai FJ: Association of interleukin-10 a-592C polymorphism in Taiwanese children with kawasaki disease. J Korean Med Sci 2009, 24:438-442.